cars spilling into the river with the worst yet to come. tucker carlson breaking his silence after his dismissal by fox news the nenew findingsgs about a diabetes drug that could be a game changer for weight loss the chananging face e of hollywood how prododuction is s being trtransformed by artificial intelligence and remembering jerry springer, beloved ringmaster of his hit talk show circus announcer: this is nbc nightly news with lester holt good evening and welcome. we begin tonight with breaking news. sources familiar with the matter tell nbc news that former vice president mike pence appeared before a federal grand jury this afternoon as part of a special counsel investigation into former president trump s attempts to overturn his 2020 election defeat. it s believed pence has direct knowledge of mr. trump s efforts to block certification of the 2020 election pence s testimony legally pitting him against the man who could very well be a rival for the 2024
shot to people here in the united states. the argument has been there are so many people in the world who need these doses that we could provide them with doses and not take a third for ourselves. dr. fauci sort of suggested that was a false choice. dr. gottlieb said yesterday, scott gottlieb, it was a false choice, there was enough vaccine to go around. what is your view on that question? there is the question of safety, but also i guess an ethical question of whether we ought to be taking boosters. yeah, willie, i ll even add to that. this is something dr. fauci and gottlieb alluded to in the past. it is also a question of those of us who are administering vaccines and talking to patients, where do we direct our focus. i still want to focus on people who are not vaccinated. i also need to focus on finding patients who might need boosters so that most important thing i fall on the line of let s look at the data. the data is clear that if you are 60 and above, there is an incredible
Share this article
Share this article
ResearchAndMarkets.com s offering.
Designing for Recruitment and Retention in Rare Disease Studies report takes a deep dive into two areas impacting the success of these studies: recruitment and retention. Given the importance of each rare disease patient, these activities are time-intensive and resource-heavy. We asked 125 respondents involved in these activities about the challenges they face, methods and support services used, and their perspectives and practices regarding patient-friendly alternatives to the clinical setting.
An area of a clinical study that is gaining momentum is a rare disease. The publisher acknowledges pharma s growing interest in this space. While this means opportunity for the drug development industry, the unique nature of rare disease studies is burdensome. Greater challenges are baked into rare disease studies compared to typical studies: very small patient pools, specialized protocols, difficult-to-define endpo
the olympics. that s right. a 16-year-old chinese swimmer wins the gold medal and denies that she is doping. ye shiwen set a record yesterday. on saturday, she won gold in the 400 meter individual medley. yesterday, the head of the world swimming association called her swim unbelievable. and suggested she may be doping. the young swimmer, she told reporters late last night and we are quoting here, my achievements derive from diligence and hard work. i will never use drugs. the chinese team is extremely strict on doping control. so i can assure you that it is not an issue with us. and women s gymnastics, the team finals happening right now. if the u.s. wins, it will be their first team gold since 1996. we ll keep you posted on that one. i want to go back to the swimming. the women s 200 meter freestyle happening in about two hours. 17-year-old american missy franklin, she is taking on the world record holder, that is fredricka pell greeny of italy. in men s swimming, michael p